Smart chemistry for traceless release of anticancer therapeutics

CJ Prange, X Hu, L Tang - Biomaterials, 2023 - Elsevier
In the design of delivery strategies for anticancer therapeutics, the controlled release of
intact cargo at the destined tumor and metastasis locations is of particular importance. To …

[HTML][HTML] Trends in 3D models of inflammatory bowel disease

B Ferreira, AS Barros, C Leite-Pereira, J Viegas… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Inflammatory bowel disease (IBD) encompasses a set of chronic inflammatory conditions,
namely Crohn's disease and ulcerative colitis. Despite all advances in the management of …

Interpenetrating Networks of Collagen and Hyaluronic Acid That Serve as In Vitro Tissue Models for Assessing Macromolecular Transport

JE Torres, F Meng, S Bhattacharya, KP Buno… - …, 2023 - ACS Publications
High-fidelity preclinical in vitro tissue models can reduce the failure rate of drugs entering
clinical trials. Collagen and hyaluronic acid (HA) are major components of the extracellular …

Anchored Cell Sheet Engineering: A Novel Scaffold‐Free Platform for in vitro Modeling

A Shahin‐Shamsabadi… - Advanced Functional …, 2024 - Wiley Online Library
Biofabricated in vitro models hold unrealized potential in accelerating drug discovery and
reducing new drug costs, but current models are overly simplified and lack physiological …

Author guide for addressing animal methods bias in publishing

CE Krebs, C Camp, H Constantino, L Courtot… - Advanced …, 2023 - Wiley Online Library
There is growing recognition that animal methods bias, a preference for animal‐based
methods where they are not necessary or where nonanimal‐based methods may already be …

Neuropathogenesis-on-chips for neurodegenerative diseases

S Amartumur, H Nguyen, T Huynh, TS Kim… - Nature …, 2024 - nature.com
Developing diagnostics and treatments for neurodegenerative diseases (NDs) is
challenging due to multifactorial pathogenesis that progresses gradually. Advanced in vitro …

[HTML][HTML] Improving in vivo assays in snake venom and antivenom research: A community discussion

AE Marriott, NR Casewell, E Lilley, JM Gutiérrez… - …, 2024 - ncbi.nlm.nih.gov
On the 26 th January 2023, a free to attend,'improving in vivo snake venom research: a
community discussion'meeting was held virtually. This webinar brought together researchers …

The challenge of making the right choice: patient avatars in the era of cancer immunotherapies

C Kayser, A Brauer, S Susanne… - Frontiers in …, 2023 - frontiersin.org
Immunotherapies are a key therapeutic strategy to fight cancer. Diverse approaches are
used to activate tumor-directed immunity and to overcome tumor immune escape. The …

Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases

PP Adhikary, T Idowu, Z Tan, C Hoang… - EMBO Molecular …, 2024 - embopress.org
Thymic stromal lymphopoietin (TSLP) is a key player in atopic diseases, which has sparked
great interest in therapeutically targeting TSLP. Yet, no small-molecule TSLP inhibitors exist …

The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological …

TK Baker, TR Van Vleet, PK Mahalingaiah… - Drug Metabolism and …, 2024 - ASPET
Microphysiological systems (MPS) are comprised of one or multiple cell types of human or
animal origins that mimic the biochemical/electrical/mechanical responses and blood-tissue …